Literature DB >> 10460350

Comparison of different methods for separation and ex vivo expansion of cord blood progenitor cells.

W Schwinger1, M Benesch, H Lackner, R Kerbl, M Walcher, C Urban.   

Abstract

Umbilical cord blood is capable of hematopoietic stem cell reconstitution in children. However, the major limitation of cord blood is a relatively low content of pluripotent progenitor cells. Thus, safe engraftment for adolescents and for adults is still not predictable and a technology for ex vivo expansion of umbilical cord blood cells is desirable. In a first step, four different methods of red cell depletion followed by magnetic cell sorting of CD34+ cells were evaluated in this study in order to assess the efficacy and safety of optimal stem cell recovery. A modified two-step Ficoll gradient separation and a hydroxyethyl starch separation tended to produce a better WBC/MNC recovery (median 94.2+/-2.44% vs. 90.2+/-5. 8%) as compared with standard Ficoll gradient separation and a gelatin-based procedure (median 78.35+/-7.1% vs. 67.2+/-5.5%). However, the recovery of CD34+ cells after magnetic cell sorting did not reach a statistically significant difference after the four different methods of red cell depletion, indicating that the recovery of WBC/MNC is not predictably correlated with the recovery of stem cells within these fractions. In a second step, we established three different cytokine combinations by adding the megakaryocyte growth and development factor +/- erythropoietin and granulocyte colony-stimulating factor to a fetal calf serum containing medium with Flt 3, stem cell factor, and interleukin-3. Net expansion of total colony-forming cells 20- to 50-fold and expansion of colony-forming cells after 5 weeks of culture 1.5- to 3-fold were obtained over a period of 7-14 days. These results demonstrate that cord blood stem cells can be expanded substantially in this short-term culture system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460350     DOI: 10.1007/s002770050530

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Evaluation of Quality Parameters for Cord Blood Donations.

Authors:  Ursula Salge-Bartels; Helga Marie Huber; Kornelia Kleiner; Peter Volkers; Rainer Seitz; Margarethe Heiden
Journal:  Transfus Med Hemother       Date:  2009-08-21       Impact factor: 3.747

2.  Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.

Authors:  Xin-Qin Kang; Wei-Jin Zang; Li-Jun Bao; Dong-Ling Li; Tu-Sheng Song; Xiao-Li Xu; Xiao-Jiang Yu
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  Differentiation of Bone Marrow: Derived Mesenchymal Stem Cells into Hepatocyte-like Cells.

Authors:  Nesrien M Al Ghrbawy; Reham Abdel Aleem Mohamed Afify; Nehal Dyaa; Asmaa A El Sayed
Journal:  Indian J Hematol Blood Transfus       Date:  2015-08-21       Impact factor: 0.900

4.  GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.

Authors:  Christiane Kuhl; Ann Atzberger; Francisco Iborra; Bernhard Nieswandt; Catherine Porcher; Paresh Vyas
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34+ Cells for Clinical Use After Myocardial Infarction.

Authors:  Claire Saucourt; Sandrine Vogt; Amandine Merlin; Christophe Valat; Anthony Criquet; Laurence Harmand; Brigitte Birebent; Hélène Rouard; Christian Himmelspach; Éric Jeandidier; Anne-Gaële Chartois-Leauté; Sophie Derenne; Laurence Koehl; Joe-Elie Salem; Jean-Sébastien Hulot; Céline Tancredi; Anne Aries; Sébastien Judé; Eric Martel; Serge Richard; Luc Douay; Philippe Hénon
Journal:  Stem Cells Transl Med       Date:  2019-04-29       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.